Page last updated: 2024-09-05

3-methyladenosine and Ovarian Neoplasms

3-methyladenosine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, Y; Liu, D; Patel, R; Qin, ZH; Ren, X; Shih, IM; Wu, H; Yang, JM; Yap, KL; Zhang, L; Zhang, Y1

Other Studies

1 other study(ies) available for 3-methyladenosine and Ovarian Neoplasms

ArticleYear
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
    Oncogene, 2012, Feb-23, Volume: 31, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein

2012